The agency charged the co-founders of the failed fecal microbiome startup with defrauding investors. The SEC is seeking a court order that would bar uBiome’s co-founders from serving as officers or directors, and require them to give up any ill-gotten gains.
CNN reported that Democratic Texas Rep. Lloyd Doggett, chair of the House Ways and Means Committee's Subcommittee on Health, had called for an investigation into the leak of Phase III data on remdesivir, which last week sent shares of Gilead Sciences soaring on the Nasdaq.
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
The company, which makes women's health drugs, said in an email that it had resolved the issue. The charges relate to alleged disclosures of nonpublic information to investment analysts in 2017 concerning interactions with the FDA.
It was reported earlier this week in The Wall Street Journal that, while an IPO without the SEC signing off is allowed with a certain workaround, it is carries legal and regulatory risks.
The firm said both funds exceeded their initial targets. Versant plans to use Fund VII for at least 20 global biotech companies, while Versant Voyageurs I will be used to fund five to eight startups with Canadian operations.
The Boston-based company said it would not pursue a planned IPO, citing "market conditions." Nasdaq had agreed to its listing on Tuesday.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The London-based biotech would trade on the Nasdaq under the ticker symbol ORTX. The move comes two months after it closed a $150 million Series C and five months after it acquired a gene therapy portfolio from GSK.
Frost, formerly Teva's chairman, is alleged in a lawsuit filed Friday to have taken part in a pump-and-dump operation that netted $27 million over five years.
The company, which has already raised more than $500 million in venture capital funding, would trade on the NASDAQ under the ticker symbol "GH."
A reporter's experience with Theranos serves as a reminder of the skepticism both journalists and healthcare consumers need to have in an age when public relations, marketing and advertising try to guide the story and our treatment.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A new $75 million investment fund has been created by Connecticut-based HealthInvest Equity Partners, according to a filing with the SEC. The investment firm, formed in 2013, focuses on a wide range of areas within healthcare, from woman’s health companies to urgent care providers to medical imaging. The company was formed when Wilf Jaeger, M.D., […]
A San Francisco-based accelerator focused solely on wearable technology and the “Internet of Things” is raising $1.2 million, according to a filing with the SEC. Wearable World, which launched its accelerator in 2013, incubates a variety of wearable developers, including several operating within the healthcare space, among them Google Glass healthcare app developers Remedy and […]
Portland-based health insurer Moda Health has raised $50 million in funding through the sale of debt, according to a filing with the SEC. The insurer, which has members in Oregon, Washington and Alaska, did not immediately respond to an inquiry from MedCity News on what it plans to use the money for. The company, headed […]
Rock Health-backed startup Amplify Health is in the midst of raising $1.5 million, according to a filing with the SEC. The San Francisco-based company, started by CEO Eric Page in 2011, has so far raised $520,000 with another $980,000 to be sold in through the sale of equity, debt and options, according to the Form D. […]
Pennsylvania-based MD Aligne, which offers telemedicine visits via smart phone or computer, has raised $400,000 on a $1 million equity and security offerings, according to a filing with the SEC. Started in 2004, MD Aligne is headed by CEO Howard Seidman. It offers telephone and online doctor consultations, medical advice and diagnoses, prescriptions and testing […]